Cite
HARVARD Citation
Furie, R. et al. (2022). B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial. Annals of the rheumatic diseases. 81 (1), pp. 100-107. [Online].